Literature DB >> 25178893

Primary CNS lymphoma in a patient treated with azathioprine.

Matilde Kanstrup Glesner1, Lukas Frans Ocias2, Thomas Stauffer Larsen2, Court Pedersen1.   

Abstract

A 33-year-old man treated with azathioprine for 12 years for Crohn's disease presented with headache, nausea and vomiting accompanied by difficulty in putting words together and slight mental confusion. Prednisolone and antibiotics were without effect. MRI of the brain showed multiple focal lesions with surrounding oedema. There was cerebrospinal fluid pleocytosis, and Epstein-Barr virus (EBV) DNA was detected in the spinal fluid by PCR. A brain biopsy confirmed the suspicion of primary brain lymphoma. EBV-associated primary brain lymphoma is a relevant differential diagnosis in patients with long-standing immune suppression presenting with neurological symptoms. Detection of EBV DNA in the spinal fluid together with characteristic radiological findings may serve as a diagnostic clue for a quick diagnosis. 2014 BMJ Publishing Group Ltd.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25178893      PMCID: PMC4158221          DOI: 10.1136/bcr-2014-205108

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  8 in total

1.  Risk of malignant lymphoma in patients with inflammatory bowel diseases: a Dutch nationwide study.

Authors:  A C W Vos; N Bakkal; R C Minnee; M K Casparie; D J de Jong; G Dijkstra; P Stokkers; A A van Bodegraven; M Pierik; C J van der Woude; B Oldenburg; D W Hommes
Journal:  Inflamm Bowel Dis       Date:  2010-12-22       Impact factor: 5.325

Review 2.  Lymphoma in inflammatory bowel disease and treatment decisions.

Authors:  Meenakshi Bewtra
Journal:  Am J Gastroenterol       Date:  2012-07       Impact factor: 10.864

Review 3.  Lymphoma and other lymphoproliferative disorders in inflammatory bowel disease: a review.

Authors:  Kavitha Subramaniam; James D'Rozario; Paul Pavli
Journal:  J Gastroenterol Hepatol       Date:  2013-01       Impact factor: 4.029

4.  Primary central nervous system lymphoma: results of a pilot and phase II study of systemic and intraventricular chemotherapy with deferred radiotherapy.

Authors:  Hendrik Pels; Ingo G H Schmidt-Wolf; Axel Glasmacher; Holger Schulz; Andreas Engert; Volker Diehl; Anton Zellner; Gabriele Schackert; Heinz Reichmann; Frank Kroschinsky; Marlies Vogt-Schaden; Gerlinde Egerer; Udo Bode; Carlo Schaller; Martina Deckert; Rolf Fimmers; Christoph Helmstaedter; Aslihan Atasoy; Thomas Klockgether; Uwe Schlegel
Journal:  J Clin Oncol       Date:  2003-11-03       Impact factor: 44.544

5.  Epstein Barr virus-associated primary CNS lymphomas in elderly patients on immunosuppressive medications.

Authors:  B K Kleinschmidt-DeMasters; Denise M Damek; Kevin O Lillehei; Ahmed Dogan; Caterina Giannini
Journal:  J Neuropathol Exp Neurol       Date:  2008-11       Impact factor: 3.685

6.  Risk of lymphoma in patients with ulcerative colitis treated with thiopurines: a nationwide retrospective cohort study.

Authors:  Nabeel Khan; Ali M Abbas; Gary R Lichtenstein; Edward V Loftus; Lydia A Bazzano
Journal:  Gastroenterology       Date:  2013-07-25       Impact factor: 22.682

7.  EBV-associated colonic B-cell lymphoma following treatment with infliximab for IBD: a new problem?

Authors:  Patrick B Allen; Georgina Laing; Aoife Connolly; Ciaran O'Neill
Journal:  BMJ Case Rep       Date:  2013-09-30

8.  EBV-associated lymphoproliferative disorder of CNS associated with the use of mycophenolate mofetil.

Authors:  Brian Patrick O'Neill; Steven Vernino; Ahmet Dogan; Caterina Giannini
Journal:  Neuro Oncol       Date:  2007-05-23       Impact factor: 12.300

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.